OSE Immunotherapeutics SA announced that at its Combined General Shareholders' Meeting held on June 22, 2023. They approved the appointment of Eric Leire as a new independent Director and of Anne-Laure Autret-Cornet, Chief Financial Officer, as Director representing the employee shareholders.